Beta-blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and spironolactone have been shown to have benefits and decrease readmissions in patients with HF with reduced ejection fraction [12-14]. Here, ACE is linked to hydrops fetalis.